A world first: Pherecydes Pharma launches multicenter clinical study of phage therapy in serious bur

For the first time, an industry-standard clinical trial is evaluating the tolerance and effectiveness of phages in fighting sensitive antibiotic-resistant infections

Publication 15/06/2015

François Ravat (Saint-Luc Saint-Joseph), Patrick Jault (Percy) and Jérôme Gabard (Pherecydes Pharma) wrote a scientific article entitled "Bactériophage et phagothérapie : utilisation de virus naturels pour traiter les infections bactériennes - Using Natural Viruses To Treat Bacterial Infections". This article was published in the journal Annals of Burn & Fire Disasters, 2015; 23(1):13-20.

Web agency Infini'click